GlassScriptPhysician profile
Michael Lamar Twede
NPI 1861450140
$11,823.42
in general payments reported to CMS, 2019-2025
31 companies · $114 in 2025
The $114 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.32 · 2020: $72.91 · 2021: $375 · 2022: $275 · 2023: $7,767 · 2024: $3,146 · 2025: $114.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $11K · Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $10,500.00 |
| Food and Beverage | $526.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,652.66 | 2023-2024 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $432.49 | 2020-2025 | Orilissa, Lo Loestrin Fe, Liletta |
| Hologic Sales and Service, LLC | $83.01 | 2021-2024 | Myosure Tissue Removal Device, Novasure |
| Pfizer INC. | $69.67 | 2022-2025 | |
| Therapeuticsmd, INC. | $56.76 | 2019-2021 | |
| Exeltis, USA INC. | $54.76 | 2021-2024 | Slynd |
| Sumitomo Pharma America, INC. | $50.63 | 2025 | Myfembree |
| Boston Scientific Corporation | $45.40 | 2022 | |
| Myovant Sciences INC. | $37.51 | 2021-2022 | |
| Ethicon US, LLC | $33.72 | 2022-2023 | Harmonic, Stratafix, Dermabond |
| Bayer Healthcare Pharmaceuticals INC. | $32.74 | 2019-2020 | |
| Avion Pharmaceuticals | $31.66 | 2021-2022 | |
| Biogen, INC. | $30.83 | 2024 | Zurzuvae |
| Sun Pharmaceutical Industries INC. | $30.33 | 2023 | Winlevi |
| Corcept Therapeutics | $24.77 | 2025 | Korlym |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $23.07 | 2023 | |
| Organon LLC | $21.02 | 2021 | |
| Idorsia Pharmaceuticals US INC | $19.67 | 2023 | Quviviq |
| Roche Diagnostics Corporation | $18.47 | 2021 | |
| Amgen INC. | $16.43 | 2019 | |
| Hologic INC | $15.81 | 2021 | |
| Merck Sharp & Dohme LLC | $14.80 | 2021 | |
| Teleflex LLC | $13.91 | 2019 | |
| Allergan, INC. | $13.30 | 2019 |
7 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Twede listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.